Navigation Links
TKXtra DataFile: Homogenous tyrosine kinase detection using High Efficiency Fluorescence Polarization

A Sensitive, Robust, Homogenous,and Rapid Assay
Uses High Efficiency Fluorescence Polarization (HEFP) detection method
Assays a broad range of tyrosine kinases
Requires no separation or wash steps
Available in a kit and in bulk packaging

Introduction
Screening for tyrosine kinase activity can be accelerated using High Efficiency Fluorescence Polarization (HEFP) assays. Molecular Devices TKXtra HEFP Assay Reagents provides a sensitive and rapid assay that is applicable for detecting the activity of numerous tyrosine kinases. For convenience and economy, the reagents can be purchased as a kit for assay evaluation and in bulk for high-throughput screening.


Intended Use
This product is designed to determine an increase or decrease in activity of tyrosine kinase in solution.


Principle of the Assay
The TKXtra system measures the activity of tyrosine kinases via a competitive immunoassay for the product of enzyme activityphosphotyrosine (pY)-containing peptides. The TKXtra procedure is a two-step process: first a kinase reaction is run, then a HEFP immunoassay is performed on the reaction products to quantify the amount of phosphopeptide formed.1


Kit Contents
The kit contains anti-phosphotyrosine antibody, fluorescein-labeled tracer, phosphotyrosine calibrator, and assay buffer. When used as suggested, each kit provides sufficient reagents for 1600 40-L assays.

For assay volumes between 440 L, HE microplates are recommended for optimal results.


Assay Conditions
Samples containing phosphopeptides produced by the tyrosine kinase assay are mixed with fluorescein-labeled tracer and anti-phosphotyrosine antibody. The samples are incubated at ambient te mperature and analyzed after 30 minutes with the same performance, using any instrument in the Criterion family.


Applications
Monitoring the activity of receptor and non-receptor tyrosine kinases

Screening of agonists or antagonists of tyrosine kinases

The TKXtra assay is capable of detecting a number of kinases. For example v-abl, EGF receptor, insulin receptor, and c-src have all been detected with good sensitivity.

Assay Performance
TKXtra calibration curve: A calibration curve was performed in a 384-well microplate. The calibrator is a phosphotyrosine peptide that closely mimics the assay response to tyrosine kinase products. This curve illustrates the nanomolar sensitivity of the TKXtra kit.


Optimization of
β−Insulin receptor kinase (β-IRk) tyrosine kinase: Titration curves were performed in a 384-well microplate using varying amounts of enzyme and three concentrations of ATP. The reaction mixture contained 5 L each of PGT (2 M final concentration), ATP and 8 L of β-IRk enzyme. After 2 hours of incubation at ambient temperature, the reaction was stopped by adding 2 L of 200 mM EDTA solution prior to running the HEFP portion of the TKXtra assay.


The data show that under the defined conditions, an assay for the β-IRk could be optimized using 0.031 nM β-IRk and 10250 M ATP.

Inhibition of β-IRk activity by staurosporine: The inhibition of the insulin receptor tyrosine kinase by staurosporine was performed in a 384-well microplate with a 20-L sample volume. The reaction mixture contained final concentrations of the following components: 2 M PGT, 25 M ATP, 0.1 nM β-IRk, and various conce ntrations of staurosporine. In the presence of 0.1 nM β-IRk and 25 M ATP, the IC50 value is 90 nM with the TKXtra kit, a figure that agrees with literature values.2

1 Seethala, R. and Menzal, R. Anal. Biochem. 255:257262 1998

2 Fujita-Yamaguchi, Y. and Kathuria, S. Biochem. Biophys. Res. Commun. 157:955962 1988


Please contact your local Molecular Devices representative for price and delivery information.


Certain aspects of the technology and design of Molecular Devices products are protected under current or pending patents.


back to top


'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. cAMP DataFile: Homogenous Cyclic AMP detection using High Efficiency Fluorescence Polarization
2. Homogeneous, chemiluminescent kinase assay kits for assessing the functional activity of a broad range of serine-threonine and tyrosine kinases
3. LiquiChip Kits for bead-based cytokine and kinase assays
4. Setting up a kinase profiler with IMAP
5. Monitoring transfection efficiency by green fluorescent protein (GFP) detection with the Agilent 2100 bioanalyzer
6. Apoptosis detection by annexin V and active caspase-3 with the Agilent 2100 bioanalyzer
7. Sensitive detection of tumor cells in peripheral blood of carcinoma patients by a reverse transcription PCR method
8. Rapid detection of genomic duplications and deletions using the Agilent 2100 bioanalyzer
9. Mutation detection for the K- rasand P16 genes
10. Multiplex protein detection with the ECL Plex fluorescent Western blotting system using the Ettan DIGE Imager
11. The combination of monolithic columns and modern HPLC/MS/MS instrumentation for high chromatographic throughput and sensitive detection of beta-agonists
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... -- Fluxion Biosciences announced today that Genetracer Biotech of ... as a Certified Service Provider for Fluxion,s IsoFlux CTC ... in Genetracer Biotech,s novel liquid biopsy workflows for detection ... plans to move to other cancers as additional assays ... to isolate, recover, and analyze CTCs (circulating tumor cells) ...
(Date:2/27/2017)... ... , ... The Catalyst Midwest premix manufacturing facility has been certified ... and private label organic services. , The first organic product is Organic 18 Percent ... of Dynamite Marketing, which owns the facility. , Catalyst already has received the ...
(Date:2/25/2017)... ... February 25, 2017 , ... ... Trials in an ongoing effort to create meaningful change by increasing communication, ... research with emphasis on consumers and patients’ mental health well-being. , Both organizations ...
(Date:2/24/2017)... ... ... Delpor, Inc. (Delpor), a biotechnology company focused on drug delivery, today announced ... for the further advancement of the company’s 3-month olanzapine product ( DLP-119 ). The ... therapeutic levels of olanzapine for a period of 3 months., “We are honored and ...
Breaking Biology Technology:
(Date:2/27/2017)... Feb. 27, 2017   Strategic Cyber Ventures , ... has led a $3.5 million investment in  Polarity , ... Cyber Ventures is DC based and is led by ... Thomas . Ron Gula , also a longtime ... participated in this series A round of funding. This ...
(Date:2/24/2017)... Feb. 24, 2017  EyeLock LLC, a leader of iris-based ... iris biometric solution on the latest Qualcomm® Snapdragon™ ... Mobile World Congress 2017 (February 27 – ... Hall 3, Stand 3E10. The ... security platform—a combination of hardware, software and ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):